On this page · 5 sections→
Where the EU money came from
Funding by EU programme. Amounts are Kws Biotest Limited's own share of each project, not the project's full budget.
- FP7 (2007 to 2013)€1.7M · 2 projects
Projects
2 EU-funded projects, newest first. Each links to the official record.
- DAVIADPartner
The development of a novel therapeutic vaccine for the selective treatment of the autoimmune disorder, Graves’ disease
FP7 (2007 to 2013) · 2013–2018 · Project on CORDIS ↗
€1.5Mtheir share - LSEPartner
LSE TECHNOLOGY APPROACH TO GENERATE INNOVATIVE KINASE INHIBITOR DRUGS
FP7 (2007 to 2013) · 2013–2015 · Project on CORDIS ↗
€202ktheir share
Works most with
Organisations that shared the most EU projects with this one. A good starting list for consortium partners.
- Nederlandse Organisatie Voor Toegepast Natuurwetenschappelijk Onderzoek TNONetherlands · 1 shared project
- University of DundeeUnited Kingdom · 1 shared project
- Glaxosmithkline Biologicals SABelgium · 1 shared project
- Apitope International NVBelgium · 1 shared project
- SERICHIM S.r.l.Italy · 1 shared project
- Creabilis Therapeutics SRLItaly · 1 shared project
- Quintiles Benefit France IncFrance · 1 shared project
- TNO Triskelion BVNetherlands · 1 shared project
Fields it works in
Research fields recorded on its Horizon projects.
- autoimmune diseases
- biomolecules
- inflammatory bowel disease
- inflammatory diseases
- pathology
- pharmacology and pharmacy
- vaccines
Is this your organisation?
Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.
Claim this profile →Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗